Posted by Michael Wonder on 01 May 2017
Reform of the Orphan Drug Program - transition arrangements
1 May 2017 - The Orphan Drug Program provides an incentive for sponsors to bring medicines for a small population to market that might otherwise not be available in Australia.
The current Orphan Drug criteria have not been reviewed in almost 20 years and changes to the Program are required to ensure that it is still fulfilling its intended purpose.
